Heron shares fly up after FDA (finally) approves its drug to rein in chemo side effects
Shares of Redwood City, CA-based Heron Therapeutics $HRTX shot up 20% on Wednesday morning after the biotech announced that the FDA has at long …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
